当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Amy Abernethy
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-06-28 , DOI: 10.1038/nrd.2018.101
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-06-28 , DOI: 10.1038/nrd.2018.101
Amy Abernethy
中文翻译:
艾米·艾伯内西(Amy Abernethy)
艾米·艾伯内西(Amy Abernethy)
更新日期:2018-06-28
Amy Abernethy, Published online: 28 June 2018; doi:10.1038/nrd.2018.101
Amy Abernethy, CSO at Flatiron Health, talks about how cleaned up and curated real-world data stands to transform clinical trials, drug regulation, competition in the health-care market and drug prices.中文翻译:
艾米·艾伯内西(Amy Abernethy)
艾米·艾伯内西(Amy Abernethy)
艾米·阿贝内西(Amy Abernethy),在线发布:2018年6月28日; doi:10.1038 / nrd.2018.101
Flatiron Health的CSO艾米·阿贝内西(Amy Abernethy)谈到清理和整理真实数据如何改变临床试验,药物监管,医疗保健市场的竞争和药品价格。